A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension - Full Text View

A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

This study has been completed.

Sponsored by:	Alcon Research
Information provided by:	Alcon Research
ClinicalTrials.gov Identifier:	NCT00326092

Purpose

The purpose of this study is to assess the comfort of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension

Condition	Intervention	Phase
Open-Angle Glaucoma Ocular Hypertension	Drug: Brinzolamide/Timolol	Phase II

Genetics Home Reference related topics:

early-onset glaucoma

MedlinePlus related topics:

Glaucoma High Blood Pressure

ChemIDplus related topics:

Azopt Timolol Timolol maleate

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study

Official Title:	A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Further study details as provided by Alcon Research:

Primary Outcome Measures:

Ocular discomfort

Estimated Enrollment:	88
Study Start Date:	April 2006
Estimated Study Completion Date:	September 2006

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Adults of either sex and any race diagnosed with open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)

Exclusion Criteria:

Under 18

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00326092

Locations


United States, Texas
	Fort Worth and Other Sites
	Fort Worth, Texas, United States, 76134

Sponsors and Collaborators

Alcon Research

Investigators


Study Director:	Julia White	Study Director

More Information

Study ID Numbers:	C-05-49
First Received:	May 12, 2006
Last Updated:	December 19, 2007
ClinicalTrials.gov Identifier:	NCT00326092
Health Authority:	United States: Food and Drug Administration

Study placed in the following topic categories:

Brinzolamide

Glaucoma

Eye Diseases

Glaucoma, Open-Angle

Vascular Diseases

Timolol

Hypertension

Ocular Hypertension

Additional relevant MeSH terms:

Carbonic Anhydrase Inhibitors

Molecular Mechanisms of Pharmacological Action

Enzyme Inhibitors

Cardiovascular Diseases

Pharmacologic Actions

ClinicalTrials.gov processed this record on September 05, 2008